You are here:

Alberta-based Sundial part of cannabis-related study for dementia

Can cannabis prove helpful for those with dementia? Central Alberta based Sundial is on a journey to find out.

Sundial Growers Inc. and the University of Saskatchewan will research together to dig deeper into cannabis-related health solutions.

As part of the collaboration, Sundial and the U of S have agreed to undertake clinical trials to study the efficacy of cannabis as a treatment for dementia.

“This unique study is the first step in our exciting collaboration, and will no doubt position the U of S as a national leader in advancing cannabis as a treatment for dementia,” Karen Chad, U of S research vice-president said in a statement.

The randomized and placebo-controlled, blinded dose-escalation study will take place at two extended care facilities in Saskatoon.

The university has chosen dementia as one area of focus for clinical trials due to serious national and international concerns about the impact dementia is having in countries with aging